Trace Neu­ro­science, a start­up spun out of Maze Ther­a­peu­tics’ pipeline, broke cov­er Tues­day morn­ing with $101 mil­lion in fund­ing to de­vel­op treat­ments for amy­otroph ...

Trace is working on genomic therapies that restore UNC13A to reestablish connections between nerves and muscle cells that have been affected by ALS. The biotech’s lead program is an antisense ...

Yes! I want to get the latest chemistry news from C&EN in my inbox every week. ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly ...

Trace Neuroscience launched on Tuesday to announce that it is developing a genetic treatment targeting UNC13A, a gene linked to both a higher risk of ALS and faster disease progression.

You can trust Louder Our experienced team has worked for some of the biggest brands in music. From testing headphones to reviewing albums, our experts aim to create reviews you can trust. Find out ...

If The Rolling Stones’ notorious free concert at Altamont in December 1969 signalled the end of the ’60s’ hippie ideal, then Aphrodite’s Child’s 666 is the sacrificial ceremony where the ...